Trial Profile
A Phase 2 trial of Bempedoic Acid / Ezetimibe Combination
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2017
Price :
$35
*
At a glance
- Drugs Bempedoic acid/ezetimibe (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 13 Sep 2017 New trial record
- 11 Aug 2017 Results published in the Media Release